Healthcare · Pharmaceuticals & Biotechnology
QVM read Quality in motion Quality Strong, Valuation Expensive, Momentum Bullish
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).
Ranks #77 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 9 Apr 2026 | ARIHANT CAPITAL MARKETS LIMITED | Bulk | Buy | 398,007 | 423.1300 | NSE |
| 2 Apr 2026 | ARIHANT CAPITAL MARKETS LIMITED | Bulk | Buy | 451,212 | 407.6000 | BSE |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 11 Aug 2026 | Financial Results/Other business matters | Yes |
| 23 May 2026 | Financial Results | Yes |
| 20 Apr 2026 | Other business matters | — |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 3 Oct 2026 | Monitoring Agency Report | Monitoring agency report for the quarter ended 30 June 2026 |
| 3 Oct 2026 | Company Update | Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report |
| 1 Oct 2026 | Company Update | Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 1 Oct 2026 | Analysts/Institutional Investor Meet/Con. Call Updates | Sai Parenterals Limited has informed the Exchange about Schedule of meet |
| 30 Sep 2026 | Company Update | Sai Parenterals Ltd - 544742 - Announcement under Regulation 30 (LODR)-Change in Management |
| 30 Sep 2026 | Insider Trading / SAST | Sai Parenterals Ltd - 544742 - Closure of Trading Window |
| 30 Sep 2026 | Others | Sai Parenterals Ltd - 544742 - Board Meeting Outcome for Board Meeting Appointment Of Mr.Ashwani Singh Bisht CS And Mr.Arvind As COO. |
| 30 Sep 2026 | Trading Window | Sai Parenterals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 30 Sep 2026 | Resignation of Director/KMP/SMP | Sai Parenterals Limited has informed the Exchange about Resignation of Director/KMP/SMP |
| 30 Sep 2026 | Change in Company Secretary/Compliance Officer | Sai Parenterals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
